Please Wait
Applying Filters...
menu
    • menu
    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Lutetium-177 Vipivotide Tetraxetan

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Pluvicto

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Pluvicto

    Lutetium Lu 177 Vipivotide Tetraxetan

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Pluvicto

    Switzerland
    arrow
    ChemOutsourcing
    Not Confirmed

    Novartis

    Lutetium Lu 177 Vipivotide Tetraxetan

    Main Therapeutic Indication : Oncology

    Currency : USD

    2022 Revenue in Millions : 271

    2021 Revenue in Millions : 0

    Growth (%) : 100

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Pluvicto

    Lutetium Lu 177 Vipivotide Tetraxetan

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Pluvicto

    Switzerland
    arrow
    ChemOutsourcing
    Not Confirmed

    Novartis

    Lutetium Lu 177 Vipivotide Tetraxetan

    Main Therapeutic Indication : Oncology

    Currency : USD

    2023 Revenue in Millions : 980

    2022 Revenue in Millions : 271

    Growth (%) : 262

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Pluvicto

    Lutetium Lu 177 Vipivotide Tetraxetan

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Pluvicto

    Switzerland
    arrow
    ChemOutsourcing
    Not Confirmed

    Novartis

    Lutetium Lu 177 Vipivotide Tetraxetan

    Main Therapeutic Indication : Oncology

    Currency : USD

    2024 Revenue in Millions : 1,392

    2023 Revenue in Millions : 980

    Growth (%) : 42

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF